statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024 Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024...

Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024

Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease Quest Diagnostics Adds p-tau217 Blood Biomarker...

Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease

Alpine Woods Capital Investors LLC raised its holdings in Quest Diagnostics Incorporated (NYSE:DGX - Free Report) by 2.1% during the fourth quarter, according to the company in its most recent Form...

Quest Diagnostics Incorporated (NYSE:DGX) Shares Bought by Alpine Woods Capital Investors LLC

Quest Diagnostics Inc's Dividend Analysis

On 4/5/24, Quest Diagnostics, Inc. (DGX), Chimera Investment Corp (CIM), and Sylvamo Corp (SLVM) will all trade ex-dividend for their respective upcoming dividends...

Ex-Dividend Reminder: Quest Diagnostics, Chimera Investment and Sylvamo

Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome...

Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay

Quest Diagnostics (NYSE:DGX - Get Free Report) and Aclarion (NASDAQ:ACON - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on...

Contrasting Quest Diagnostics (NYSE:DGX) and Aclarion (NASDAQ:ACON)

Palumbo Wealth Management LLC decreased its position in Quest Diagnostics Incorporated (NYSE:DGX - Free Report) by 1.1% during the 4th quarter, Holdings Channel reports. The firm owned 18,068 shares...

Palumbo Wealth Management LLC Sells 192 Shares of Quest Diagnostics Incorporated (NYSE:DGX)

Raymond James  Associates increased its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX - Free Report) by 103.3% during the fourth quarter, according to its most recent...

Raymond James & Associates Raises Holdings in Quest Diagnostics Incorporated (NYSE:DGX)

Quest Diagnostics Incorporated (NYSE:DGX - Get Free Report) has received an average rating of "Hold" from the eleven analysts that are covering the stock, Marketbeat reports. Nine research analysts...

Brokerages Set Quest Diagnostics Incorporated (NYSE:DGX) Price Target at $144.18

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Volume	601,735.00
52-Wk High	$145.58
52-Wk Low	$119.59

DGX Quest Diagnostics, Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals